My Notes

There are 600 + physicians and other health care providers practicing within 18 different clinical entities, or specialty groups that are affiliated with Stony Brook University Physicians (SBU Physicians). Together, these providers offer patients of all ages a comprehensive range of high quality medical services, from primary care to advanced specialty care. The physicians and health care professionals affiliated with SBU Physicians are committed to excellence in service and leadership in clinical care. In their capacity as faculty of the Stony Brook University School of Medicine, they also educate medical students, interns, residents and fellows in many specialties and sub-specialties, and engage in research and clinical trials that help to advance the science of medicine.

My Articles

Lau YH, Susskind H, Weber DA, Park TL, Atkins HL, Franceschi D, Meek AG, Ivanovic M and Wielopolski L. Acute Permeability Changes of Alveolar Epithelium as Early Indicator of Radiation Pneumonitis in Treatment of Lung and Breast Carcinoma. RSNA, 1995. 18) Meek AG, Park TL, Weiss TE and Bethune WA. Impact on Local Control of the Time Interval Between Diagnosis and Institution of Radiotherapy for Breast Conservation in Stages 0, 1 and 2 Breast Cancer. RSNA, 1995. 19) Lau YH, Park TL, Meek AG, Pinsky J and Noble A. Biochemical Failure Free Survival Following Radiotherapy for Prostate Cancer. ASTRO PSA Symposium, September, 1996. 20) Amber K, Anderson J, Smith C, Georggson M, Comer G, Park T, Birk J. A Prospective Randomized Placebo-Controlled Double-Blinded Trial of Misoprostol Rectal Suppositories in the Prevention of Acute Radiation Proctitis in Prostate Cancer Patients. September, 1998. 21) Park TL, Meek AG, Pai S, Xu Z, Waltzer W, Park PK, and Pinsky J. The Comparison of Biochemical Disease-Free Survival Between Iodine-125 and Palladium-103 Brachytherapy for Prostate Cancer. RSNA, 2000. 22) Meek AG, Park TL, Kim A, Waltzer W, Munkelwitz R, Adler H, Park PK, and Pinsky JJ. Biochemical Disease-Free Survival Following Transperineal Iodine-125 or Palladium-103 Prostate Implantation in Clinically Localized Prostate Cancer. RSNA, 2000.